Overview
Short Courses*: October 17
Meeting: October 18-19
Short Course 1: Plain Language Labeling: Implementing Health Canada’s Guidance for Industry
*Short Courses require registration and an additional fee.
Innovation to support collaboration, engagement, and openness across the Canadian health care landscape
There has been an increased call and focus on innovation and collaboration across the health product development and regulatory system in Canada. The 2016-17 Budget announced by the Government of Canada placed an important emphasis on developing Canada’s culture of innovation. Health Canada continues to support this effort with their strategic plans and priorities, new and ongoing openness and transparency initiatives, and opportunities for engagement and collaboration with industry, patients, provinces and territories, and many other stakeholder groups.
What does innovation mean to you? The DIA Annual Canadian Meeting 2016 will bring together key thought leaders, industry experts, academics, medical professionals, and Health Canada representatives, to explore how innovation can drive and support new initiatives, regulatory processes, research, transparency, engagement, personalized medicine, use of real-world data, and much more!
This year’s meeting will feature plenary sessions, multi-track breakout sessions, networking opportunities, short courses, round table lunch discussions, and tabletop exhibiting opportunities. There will be sessions tailored to the beginner, intermediate, and advanced level professional.
Network early and start engaging on social media using the hashtag #DIACanada2016.
Community Outreach Event
Join us in giving back to the community! This year, we are partnering with the Children’s Hospital of Eastern Ontario (CHEO) to kick off the DIA Annual Canadian Meeting 2016 with a community outreach activity!
For more information visit the Registration page.
Program Committee
-
Marilena Bassi, MA Senior Executive Director, Therapeutic Products Directorate
Health Canada, Canada -
Deirdre Cozier Director, Global Regulatory Affairs
Pharmascience, Canada -
Loretta Del Bosco Director, Regulatory Affairs Quality Assurance Operations
AbbVie Corporation, Canada -
Laura Durno, MS, MSc Acting Chief, Viral Vaccines Division
Biologics and Genetic Therapies Directorate, Health Canada, Canada -
Karen Feltmate President
Redstone Health Group, Inc., Canada -
Maggie Graham Senior Policy Analyst, Natural and Non-Prescription Health Products Directorate
Health Canada, Canada -
Vratislav Hadrava, MD, PhD Vice President and Medical Director, Global Innovative Products
Pfizer Canada, Inc., Canada -
Keith McIntosh Executive Director, Scientific & Regulatory Affairs
Innovative Medicines Canada, Canada -
Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada -
Matthew Ryan Senior Policy Analyst; Policy, Planning and International Affairs Directorate
Health Canada, Canada
Have an account?